NVO
Novo Nordisk A/SHealthcare$36.98
▲ Bullish
Mkt Cap: $164.13B|Float: 3.19B|SI: 0.8%|DTC: 1.0
Data as of market close Apr 2, 2026
IV Rank
18
IV Pctl
11%
HV 20d
2552.0%
52W Range
$35-$81
ATR(14)
$1.01
Exp. Move
±4.6%
P/C Ratio
0.69
Earnings
May 6
GEX Positive
DEX Long
Net Put Premium
IV Low
Exp. Move Wide
Low Put/Call
NVO Key Options Data
- IV Rank
- 17.8%
- Total GEX
- $0.00B
- Total DEX
- $37.9M
- Max Pain
- $37.00
- Expected Move
- ±4.6%
- Put/Call OI
- 0.69
- Net Premium
- $-35.7M
- Spot Price
- $36.98
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$1.70 | ±4.6% | $35.28 | $38.68 |
| 2026-04-17 | 15 | ±$2.43 | ±6.6% | $34.55 | $39.41 |
| 2026-04-24 | 22 | ±$3.01 | ±8.1% | $33.97 | $39.99 |
| 2026-05-01 | 29 | ±$3.50 | ±9.4% | $33.48 | $40.47 |
| 2026-05-08 | 36 | ±$4.61 | ±12.5% | $32.37 | $41.59 |
| 2026-05-15 | 43 | ±$5.39 | ±14.6% | $31.58 | $42.37 |
Explore NVO options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.